Ophthalmology · Portland, OR
NPI
1124042692
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1955 NW Northrup St
Portland, OR, 97209
Phone (503) 227-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$204K
2,150 services
Medicare patients, 2024
894
Average age 76
Drug cost, 2024
$116K
2,634 prescriptions
Company payments, 2024
$155
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca L Armour was code 92014 (ophthalmological e&m), 440 times for 428 patients. In total Rebecca L Armour billed 2,150 services in 32 codes, and Medicare paid $204K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 440 | 428 | $85.65 | $38K |
| 99214 Office E&M - Established | Office | 350 | 279 | $85.01 | $30K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 181 | 123 | $12.71 | $2,300 |
| 92133 Computerized Ophthalmic Imaging | Office | 178 | 177 | $26.29 | $4,680 |
| 92134 Computerized Ophthalmic Imaging | Office | 167 | 154 | $30.86 | $5,153 |
| 92083 Vision, Hearing, and Speech Services | Office | 158 | 151 | $46.67 | $7,374 |
| 66984 Cataract Surgery | Facility | 151 | 87 | $455.71 | $69K |
| 92136 Ultrasound - Nonspecific | Office | 134 | 102 | $29.67 | $3,976 |
| 99213 Office E&M - Established | Office | 75 | 71 | $65.92 | $4,944 |
| 66821 Cataract Surgery | Facility | 73 | 55 | $266.57 | $19K |
| 92004 Ophthalmological E&M | Office | 65 | 65 | $102.47 | $6,661 |
| 99204 Office E&M - New | Office | 54 | 54 | $104.50 | $5,643 |
| 92012 Ophthalmological E&M | Office | 28 | 27 | $62.23 | $1,742 |
| 99212 Office E&M - Established | Office | 20 | 20 | $46.51 | $930 |
| 76514 Ultrasound - Nonspecific | Office | 20 | 20 | $7.94 | $159 |
By year: 2022 $198K for 1,926 services; 2023 $191K for 1,837 services; 2024 $204K for 2,150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca L Armour prescribed most often to Medicare patients was Latanoprost, with 870 prescriptions and refills. In total Rebecca L Armour wrote 2,634 Medicare prescriptions that cost $116K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 870 | 1,839 | 230 | $11K |
| Timolol Maleate Generic | 406 | 859 | 133 | $5,489 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 283 | 545 | 89 | $4,684 |
| Levobunolol Hcl Generic | 228 | 443 | 50 | $5,116 |
| Prednisolone Acetate Generic | 116 | 167 | 80 | $5,741 |
| Brimonidine Tartrate Generic | 100 | 211 | 30 | $2,801 |
| Ofloxacin Generic | 91 | 91 | 59 | $1,122 |
| Dorzolamide Hcl Generic | 87 | 166 | 23 | $1,408 |
| Ketorolac Tromethamine Generic | 80 | 86 | 52 | $1,747 |
| Erythromycin Erythromycin Base | 56 | 61 | 44 | $798 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 52 | 54 | 45 | $666 |
| Lumigan Bimatoprost | 36 | 87 | 11 | $24K |
| Travoprost Generic | 35 | 60 | Under 11 | $4,102 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 32 | 46 | Under 11 | $3,851 |
| Cyclosporine Generic | 21 | 39 | Under 11 | $15K |
Brand drugs: 597 claims; generic drugs: 2,037 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Rebecca L Armour $155 ($155 in general payments such as food, travel and fees) from 1 company. The largest payer was RxSight Inc with $155.
| Company | Payments | Amount |
|---|---|---|
| RxSight Inc RXST | 1 | $155 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.